National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 
 
Results: 1 -10 of 27    Show     results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

   
Phase III

   
CAN-NCIC-MAP3
PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3

 
 
Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

   
Phase III

   
UHM-CHS-4116
CHS 14116, NCT00513916

 
 
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

   
Phase III

   
IBCSG-35-07
IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, NCT00553410

 
 
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

   
Phase III

   
FNCLCC-ONCO-03/0701
FNCLCC-ONCO 03/0701 - LIBER, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, NCT00673335

 
 
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

   
Phase III

   
ACCOG-HER-PCI
ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366

 
 
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

   
Phase II

   
CHNMC-IRB-02164
NCT00080756

 
 
Exemestane in Treating Postmenopausal Women at High Risk for Invasive Breast Cancer

   
Phase II

   
GUMC-2007-313
NCI-04-C-0044, NCT00085072, GUMC-2007-313, GT 07-313, 2007-313

 
 
Letrozole in Preventing Breast Cancer in Postmenopausal Women

   
Phase II

   
DFCI-00024
UCLA-0210012-02, NCT00090857

 
 
Soy Protein and Breast Cancer Risk Reduction

   
Phase II

   
02-422
Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477

 
 
Soy Isoflavones and Breast Cancer Risk Reduction

   
Phase II

   
03-260
UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490

 
      1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov